Live Breaking News & Updates on Drug pricing reduction act

Stay informed with the latest breaking news from Drug pricing reduction act on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Drug pricing reduction act and stay connected to the pulse of your community

FTC's PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector | Epstein Becker & Green

On June 7, 2022, the Federal Trade Commission (FTC) unanimously voted to initiate a study into how business practices employed by some pharmacy benefit managers (PBMs) may impact...

United-states , West-virginia , Americans , Us-congress , Senate-finance-committee , Care-management-association , Office-of-inspector , Scripts-inc , Agency-activity-related-to-drug-pricing , Us-senate-parliamentarian , Departments-of-health

Ramping up the drug pricing debate: Dueling bills and paying for health care infrastructure | Hogan Lovells

To embed, copy and paste the code into your website or blog:
The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced version of the Democrat-led “Elijah E. Cummings Lower Drug Costs Now Act,” originally introduced in 2019 (and hereinafter referred to) as H.R. 3. Although the bills diverge in various material respects, both would implement sweeping changes related to drug coverage and price reporting. At the same time that the House considers these proposals, Senate Democrats are urging President Biden to include major drug pricing legislation in the second phase of his infrastructure plan. The White House has been silent to date on whether drug pricing will be addressed in the next proposed infrastructure package.

United-states , Canada , Americans , Elijahe-cummings , Centers-for-medicare-medicaid-services , Human-services , Fair-price-negotiation-implementation-fund-for , Labor-committee-ranking-member-virginia-foxx , House-energy , Means-committee-ranking-member-kevin-brady , Labor-to-congress